Why the study?
Antipsychotic drug use is a known risk for thromboembolism, but this risk has not been sufficiently analyzed in the Japanese population.
Does antipsychotic drug use increase the risk of thromboembolism and serious consequences in a Japanese population?
Does antipsychotic drug use increase the risk of thromboembolism and serious consequences in a Japanese population?
This study aims to evaluate the risk of thromboembolism associated with antipsychotic drug use in the Japanese population using a national adverse event database.
Answers are grounded in this paper and cite their sources.
Supports monitoring for thromboembolism with antipsychotics; leaves open causal confirmation in Japanese patients.
The use of antipsychotic drugs is a known risk for thromboembolism, but this risk has not been sufficiently analyzed in the Japanese population. We aimed to analyze the association between antipsychotic drug use and thromboembolism in a Japanese population and to clarify the factors that lead to serious consequences.
No takes yet. Share an insight, caveat, or question.
Maeshima et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: